239 related articles for article (PubMed ID: 23978127)
1. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.
Li ZG; Li G; Zhou YL; Chen ZJ; Yang JQ; Zhang Y; Sun S; Zhong SL
Lipids Health Dis; 2013 Aug; 12():127. PubMed ID: 23978127
[TBL] [Abstract][Full Text] [Related]
2. Investigation of LPA sequence variants rs6415084, rs3798220 with conventional coronary artery disease in Iranian CAD patients.
Rouhani B; Ghaderian SMH; Salehi Z
Hum Antibodies; 2019; 27(2):99-104. PubMed ID: 30594920
[TBL] [Abstract][Full Text] [Related]
3. Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia.
Page MM; Ellis KL; Pang J; Chan DC; Hooper AJ; Bell DA; Burnett JR; Watts GF
Clin Chim Acta; 2020 Nov; 510():211-215. PubMed ID: 32681934
[TBL] [Abstract][Full Text] [Related]
4. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
[TBL] [Abstract][Full Text] [Related]
5. Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease.
Anderson JL; Knight S; May HT; Horne BD; Bair TL; Huntinghouse JA; Rollo JS; Muhlestein JB; Carlquist JF
Am J Cardiol; 2013 Sep; 112(6):799-804. PubMed ID: 23735648
[TBL] [Abstract][Full Text] [Related]
6. LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography.
Santos PC; Bueno CT; Lemos PA; Krieger JE; Pereira AC
Lipids Health Dis; 2014 Apr; 13():74. PubMed ID: 24776095
[TBL] [Abstract][Full Text] [Related]
7. Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease.
Wang L; Chen J; Zeng Y; Wei J; Jing J; Li G; Su L; Tang X; Wu T; Zhou L
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1989-96. PubMed ID: 27417586
[TBL] [Abstract][Full Text] [Related]
8. Association of β-adrenergic receptor genes polymorphisms with incidence of subsequent cardiovascular events in Han Chinese patients with coronary artery disease.
Li ZG; Wu H; Zhou YL; Chen ZJ; Meng JX; Yang JQ; Chen JY; Zhong SL
Chin Med J (Engl); 2013; 126(24):4679-84. PubMed ID: 24342311
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
[TBL] [Abstract][Full Text] [Related]
10. Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events.
Gu JX; Huang J; Li SS; Zhou LH; Yang M; Li Y; Zhang AM; Yin Y; Zhang N; Jia M; Su M
Sci Rep; 2022 Mar; 12(1):3588. PubMed ID: 35246583
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
Takahashi N; Dohi T; Funamizu T; Endo H; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
J Cardiol; 2020 Jul; 76(1):25-29. PubMed ID: 32089480
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
[TBL] [Abstract][Full Text] [Related]
13. Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention.
Suwa S; Ogita M; Miyauchi K; Sonoda T; Konishi H; Tsuboi S; Wada H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Daida H
J Atheroscler Thromb; 2017 Nov; 24(11):1125-1131. PubMed ID: 28321012
[TBL] [Abstract][Full Text] [Related]
14. Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians.
Khalifa M; Noureen A; Ertelthalner K; Bandegi AR; Delport R; Firdaus WJ; Geethanjali FS; Luthra K; Makemaharn O; Pang RW; Salem AH; Sasaki J; Schiefenhoevel W; Lingenhel A; Kronenberg F; Utermann G; Schmidt K
Atherosclerosis; 2015 Oct; 242(2):521-8. PubMed ID: 26302166
[TBL] [Abstract][Full Text] [Related]
15. Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome.
Hao Y; Yang Y; Wang Y; Li J
Curr Med Res Opin; 2022 Oct; 38(10):1663-1672. PubMed ID: 35575139
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 genotypes modulate the long-term effect of lipoprotein(a) on cardiovascular events: The Ioannina Study.
Naka KK; Bechlioullis A; Marini A; Sionis D; Vakalis K; Triantis G; Wilkins L; Rogus J; Kornman KS; Witztum JL; Doucette-Stamm L; Michalis LK; Tsimikas S
J Clin Lipidol; 2018; 12(2):338-347. PubMed ID: 29310992
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention.
Xu N; Tang XF; Yao Y; Jia SD; Liu Y; Zhao XY; Chen J; Gao Z; Yang YJ; Gao RL; Xu B; Yuan JQ
Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):265-273. PubMed ID: 31740238
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.
Qi Q; Workalemahu T; Zhang C; Hu FB; Qi L
Eur Heart J; 2012 Feb; 33(3):325-34. PubMed ID: 21900290
[TBL] [Abstract][Full Text] [Related]
19. A genome-wide association study on lipoprotein (a) levels and coronary artery disease severity in a Chinese population.
Liu Y; Ma H; Zhu Q; Zhang B; Yan H; Li H; Meng J; Lai W; Li L; Yu D; Zhong S
J Lipid Res; 2019 Aug; 60(8):1440-1448. PubMed ID: 31186284
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) and the risk of recurrent events in patients with acute myocardial infarction treated by percutaneous coronary intervention.
Rigattieri S; Cristiano E; Tempestini F; Lo Monaco M; Cava F; Bongiovanni M; Tifi P; Berni A; Volpe M
Minerva Cardiol Angiol; 2023 Aug; 71(4):406-413. PubMed ID: 36321889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
